Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries has launched an innovative mobile app to connect doctors with asthma patients. The company has developed the app to facilitate doctors to track treatment progress of their patients and increase compliance to medication for better management of asthma.

It is estimated that nearly 50 per cent to 70 per cent patients in India do not adhere to asthma treatment regimen recommended by a doctor. Sun Pharma’s RespiTrack app aims to address these and other reasons leading to non-adherence thereby improving compliance to Asthma treatment through recurring medication reminders, pre-programmed alerts, over-the-air review by the doctor etc.

Sun Pharma is the world’s fifth largest specialty generic pharmaceutical company and India’s top pharmaceutical company. Its global presence is supported by 49 manufacturing facilities spread across 6 continents, R&D centres across the globe and a multi-cultural workforce comprising over 50 nationalities.